Light Sciences Oncology Email Format
Pharmaceutical ManufacturingWashington, United States11-50 Employees
Light Sciences Oncology (LSO) is a pharmaceutical manufacturing company based in Bellevue, Washington, focused on developing Aptocine, a water-soluble photosensitizing agent used in the treatment of solid tumors and other conditions such as benign prostatic hyperplasia. Aptocine is paired with a single-use drug activator to enable controlled, repeatable treatments, with the goal of delivering tolerable and effective therapy for patients. The company has pursued clinical development across multiple indications, including hepatocellular carcinoma and metastatic colorectal cancer, and is advancing trials in BPH while supporting research in neurofibromatosis as well as applications in cardiovascular, eye, and dermatological diseases. LSO operates in the pharmaceutical manufacturing sector and has positioned its Aptocine program within a broad pipeline supported by intellectual property and ongoing development efforts.